Drug Type Small molecule drug |
Synonyms Molisidomine, Molsidomine (JAN/USAN/INN), CAS-276 + [1] |
Target- |
Mechanism Nitric oxide donors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date BE (10 Feb 2004), |
Regulation- |
Molecular FormulaC9H14N4O4 |
InChIKeyXLFWDASMENKTKL-UHFFFAOYSA-N |
CAS Registry25717-80-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01320 | Molsidomine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Angina Pectoris | BE | 10 Feb 2004 | |
Heart Failure | - | - | - |
Myocardial Infarction | - | - | - |
Not Applicable | 28 | Molsidomin 2 mg | sebmanyqxu(cyrvtctbgd) = avngysljuj dqkhgjirxk (gkxxkprpgv ) View more | Positive | 04 Sep 2022 | ||
Placebo | sebmanyqxu(cyrvtctbgd) = siosgvgoas dqkhgjirxk (gkxxkprpgv ) View more |